Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Ra Medical Systems, Inc. (RMED) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Catheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q Fort Mill, SC, August 25, 2023 – Catheter Precision, Inc. announced today that on August 22, 2023, the Company received a notice from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American under the timely filing criteria set forth in Section 1007 of the NYSE American Company Guide . The non-compliance results from the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 by the extended filing due date of August 21, 2023 . As previously disclosed, the delay in the filing of the Company's Quarterly Report relates principally to additional time that is needed to complete..."
08/15/2023 8-K Results of Operations and Financial Condition  Interactive Data
08/04/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Certificate of Amendment of Certificate of Incorporation of Ra Medical Systems, Inc. Filed August 1, 2023 and Effective August 17, 2023"
07/25/2023 8-K Quarterly results
07/20/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
07/14/2023 8-K Quarterly results
07/07/2023 SD Form SD - Specialized disclosure report:
07/07/2023 8-K Unregistered Sales of Equity Securities  Interactive Data
06/02/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/30/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Ra Medical Systems Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q Fort Mill, SC, May 30, 2023 – Ra Medical Systems, Inc. announced today that on May 23, 2023, the Company received a notice from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American under the timely filing criteria set forth in Section 1007 of the NYSE American Company Guide . The non-compliance results from the Company’s previously disclosed failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 by the extended filing due date of May 22, 2023 . As previously disclosed, the delay in the filing of the Company's Quarterly Report relates principally to completion of the auditor’s r..."
05/25/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/25/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/16/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Ra Medical Systems Provides First Corporate Update Since Merger"
05/16/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/12/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
05/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/24/2023 8-K Quarterly results
04/21/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
04/18/2023 8-K Quarterly results
04/06/2023 D Form D - Notice of Exempt Offering of Securities:
03/31/2023 8-K/A Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Financial Statements and Exhib...
03/31/2023 SC 13G R. Randall Rollins Voting Trust U/A dated August 25, 1994 reports a 5.2% stake in Ra Medical Systems, Inc.
03/29/2023 8-K/A Quarterly results
03/29/2023 8-K Quarterly results
03/28/2023 10-K Annual Report for the period ended December 31, 2022
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
03/15/2023 4 McGuire Jonathan Will (CEO & Secretary) has filed a Form 4 on Ra Medical Systems, Inc.
Txns: Paid exercise price by delivering 84 shares @ $2.67, valued at $224.3
02/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/24/2023 8-K Other Events  Interactive Data
02/10/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy